ArticleBritish journal of pharmacology2019

Effects of the FGF receptor-1 inhibitor, infigratinib, with or without sildenafil, in experimental pulmonary arterial hypertension.

Nathane Santanna Felix et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.